1. A researcher suspects that the actual prevalence of generalized anxiety among children and adolescents is higher than the previously reported prevalence of generalized anxiety disorder among children and adolescents. The previously reported prevalence of generalized anxiety disorder among children and adolescents is 4.1%, and the researcher conducts a study to test the accuracy of the previously reported prevalence of generalized anxiety disorder by recruiting 98 children and adolescents from various pediatricians' offices and tests them for generalized anxiety disorder using the DSM-5. The researcher determines that the prevalence of generalized anxiety disorder among the participants of the study is 6.8%. The researcher's hypothesis, for a level of significance of 5%, should resemble which of the following sets of hypothesis?

A) H₀: p > .041; H₁: p = .041; alpha= .05

B) H₀: p > .041; H₁: p = .041; alpha= .95

C) H₀: p = .041; H₁: p > .041; alpha= .05

D) H₀: p = .041; H₁: p > .041; alpha= .95

2. A researcher suspects that the actual prevalence of generalized anxiety among children and adolescents is higher than the previously reported prevalence of generalized anxiety disorder among children and adolescents. The previously reported prevalence of generalized anxiety disorder among children and adolescents is 4.1%, and the researcher conducts a study to test the accuracy of the previously reported prevalence of generalized anxiety disorder by recruiting 98 children and adolescents from various pediatricians' offices and tests them for generalized anxiety disorder using the DSM-5. The researcher determines that the prevalence of generalized anxiety disorder among the participants of the study is 6.8%. Calculate the z value for the test statistic.

A) z = 1.12

B) z = 1.09

C) z = 43.56

D) z = 1.35

3. A researcher suspects that the actual prevalence of generalized anxiety among children and adolescents is higher than the previously reported prevalence of generalized anxiety disorder among children and adolescents. The previously reported prevalence of generalized anxiety disorder among children and adolescents is 4.1%, and the researcher conducts a study to test the accuracy of the previously reported prevalence of generalized anxiety disorder by recruiting 98 children and adolescents from various pediatricians' offices and tests them for generalized anxiety disorder using the DSM-5. The researcher determines that the prevalence of generalized anxiety disorder among the participants of the study is 6.8%. For a level of significance of 5%, what should the researcher's decision rule look like?

A) Reject H₀ if z is less than or equal to -1.96.

B) Reject H₀ if z is greater than or equal to 1.96.

C) Reject H₀ if z is less than or equal to -1.645.

D) Reject H₀ if z is greater than or equal to 1.645.

4. A researcher suspects that the actual prevalence of generalized anxiety among children and adolescents is higher than the previously reported prevalence of generalized anxiety disorder among children and adolescents. The previously reported prevalence of generalized anxiety disorder among children and adolescents is 4.1%, and the researcher conducts a study to test the accuracy of the previously reported prevalence of generalized anxiety disorder by recruiting 98 children and adolescents from various pediatricians' offices and tests them for generalized anxiety disorder using the DSM-5. The researcher determines that the prevalence of generalized anxiety disorder among the participants of the study is 6.8%. What should the researcher's conclusion be for a 5% significance level?

A) We reject H₀ at the 5% level because 1.35 is less than -1.96. We do have statistically significant evidence to show the actual prevalence of generalized anxiety disorder among children and adolescents is above the previously reported prevalence of 3.9%.

B) We fail to reject H₀ at the 5% because 1.12 is less than 1.645. We do not have statistically significant evidence to show the actual prevalence of generalized anxiety disorder among children and adolescents is above the previously reported prevalence of 3.9%.

C) We fail to reject H₀ at the 5% because 1.09 is less than 1.96. We do not have statistically significant evidence to show the actual prevalence of generalized anxiety disorder among children and adolescents is above the previously reported prevalence of 3.9%.

D) We fail to reject H₀ at the 5% because 43.56 is greater than 1.645. We do not have statistically significant evidence to show the actual prevalence of generalized anxiety disorder among children and adolescents is above the previously reported prevalence of 3.9%.

5. A new drug to treat psoriasis has been developed and is in clinical testing. Assume that those individuals given the drug are examined before receiving the treatment and then again after receiving the treatment to determine if there was a change in their symptom status. If the initial results showed that 3.0% of individuals entered the study in remission, 74.0% of individuals entered the study with mild symptoms, 13.0% of individuals entered the study with moderate symptoms, and 4.0% entered the study with severe symptoms calculate and interpret a chi-squared test to determine if the drug was effective treating psoriasis given the information below from the final examination.

Remission (No Symptoms of Psoriasis)

Mild Symptoms of Psoriasis

Moderate Symptoms of Psoriasis

Severe Symptoms of Psoriasis

Total Number of Participants to Receive the Drug

Number of Participants

455

635

85

7

1182

A) We reject H0 because 5094.4 is greater than 5.99. We have statistically significant evidence at the alpha equals .05 level to show that the distribution of the severity of psoriasis cases at the end of the clinical trial for the sample is different from the distribution of the severity of psoriasis cases prior to the administration of the drug, suggesting the drug is effective.

B) We reject H0 because 5094.4 is greater than 9.51. We have statistically significant evidence at the alpha equals .05 level to show that the distribution of the severity of psoriasis cases at the end of the clinical trial for the sample is different from the distribution of the severity of psoriasis cases prior to the administration of the drug, suggesting the drug is effective.

C) We reject H0 because 5094.4 is greater than 7.81. We have statistically significant evidence at the alpha equals .05 level to show that the distribution of the severity of psoriasis cases at the end of the clinical trial for the sample is different from the distribution of the severity of psoriasis cases prior to the administration of the drug, suggesting the drug is effective.

D) We reject H0 because 5094.4 is greater than 11.07. We have statistically significant evidence at the alpha equals .05 level to show that the distribution of the severity of psoriasis cases at the end of the clinical trial for the sample is different from the distribution of the severity of psoriasis cases prior to the administration of the drug, suggesting the drug is effective.

6. True or False? For a two-tailed test using z values at the 5% significance level we reject H₀ if z -1.960 or if z 1.960

7. True or False? Assume a researcher recruits 150 African American and Caucasian individuals taking warfarin to determine if there is a difference in the mean dosage of the medication needed to cause a decrease in their INR blood test. If the mean dosage for 75 Caucasian individuals required to get their INR blood test in range is 6.1 mg with a standard deviation of 1.7 mg and the mean dosage for 75 African American individuals required to get their INR blood test in range is 4.3 mg with a standard deviation of 0.9 mg, the S_p value obtained while calculating the test statistic is approximately 1.10 mg.

8. True or False? Assume a researcher recruits 150 African American and Caucasian individuals taking warfarin to determine if there is a difference in the mean dosage of the medication needed to cause a decrease in their INR blood test. If the mean dosage for 75 Caucasian individuals required to get their INR blood test in range is 6.1 mg with a standard deviation of 1.7 mg and the mean dosage for 75 African American individuals required to get their INR blood test in range is 4.3 mg with a standard deviation of 0.9 mg, the z value obtained while calculating the test statistic is approximately 9.60.

9. True or False? Assume a researcher recruits 150 African American and Caucasian individuals taking warfarin to determine if there is a difference in the mean dosage of the medication. If the mean dosage for 75 Caucasian individuals required to get their INR blood test in range is 6.1 mg with a standard deviation of 1.7 mg and the mean dosage for 75 African American individuals required to get their INR blood test in range is 4.3 mg with a standard deviation of 0.9 mg, the decision rule for a 10% level of significance would be to reject H₀ if z -1.645 or z 1.645

10. True or False? H₀ for an ANOVA test often states that all the mean values from the different independent samples are not equal.